Location: Home > Cardiovascular Devices
Cardiovascular Devices
Author：Interventional Cardiology ArchitectTAVR Valves: Clinical Access Trends and Selection Signals for 2026TAVR valves in 2026: explore clinical access trends, physician selection signals, and sourcing pressures shaping market advantage, premium positioning, and smarter procurement decisions.May 16, 2026- Author：Interventional Cardiology ArchitectDrug Eluting Stents: Cost vs Patency in Value-Based PurchasingDrug eluting stents cost more upfront, but do they deliver better long-term value? Explore patency, reintervention risk, and evidence to make smarter purchasing decisions.May 16, 2026
- Author：Interventional Cardiology ArchitectCardiovascular Device Development Bottlenecks Before SubmissionCardiovascular device development often stalls before submission. Explore key bottlenecks in evidence, testing, clinical strategy, and regulatory alignment to reduce delays and improve approval confidence.May 12, 2026
Author：{item.goods_category_9q0k9j8pjx}
{item.title}
{item.description}
{item.add_time}
Weekly Insights
Stay ahead with our curated technology reports delivered every Monday.
Related Industries
- Biodegradable Implants: Safety and Degradation RisksBiodegradable implants offer healing benefits, but safety depends on controlled degradation, byproducts, tissue response, and real-world clinical evidence.
- Medical Device Regulations: 2026 Access RisksMedical device regulations in 2026 may reshape access, pricing, and evidence demands. Learn how IMCS helps leaders reduce risk and defend market value.
- Osseointegration Technology in 3D Printed Ti ImplantsOsseointegration technology in 3D printed Ti implants improves bone ingrowth, fixation, and long-term stability. Learn key design, safety, and procurement factors.